Administrative Guidances
The FDA updated its Vaccines, Blood & Biologics division website to provide a consolidated list of administrative guidance documents.
Manufacturers and sponsors of biologic products, including vaccines and blood products, as well as regulatory and administrative departments managing submissions to CBER.
Administrative guidances typically outline the non-clinical and non-technical procedures for interacting with the Agency. While the source provides limited detail on the specific content of these guidances, centralizing these documents suggests an effort to streamline administrative transparency. Regulatory teams likely need to ensure their procedural workflows for submissions and formal communications remain compliant with the latest administrative protocols listed on this page.
Regulatory teams should periodically monitor this administrative guidance index for updates to ensure their submission procedures and corporate interactions align with the most current CBER administrative frameworks. Review any newly listed documents to confirm that internal standard operating procedures reflect current FDA administrative expectations.